<DOC>
	<DOCNO>NCT02351050</DOCNO>
	<brief_summary>The aim project demonstrate fibrinolytic effect sonothrombolysis ( continual transcranial Doppler monitoring ) use 2 MHz diagnostic probe reduction risk brain infarction due activation endogenous fibrinolytic system angioplasty stenting coronary artery . 120 patient indicate coronary angioplasty stenting enrol study order demonstrate twenty-percent risk reduction number volume brain infarction detect use MRI examination 24 hour cardiac endovascular treatment 5 % level significance . Patients randomize - subgroup 1 undergo 40-240 minute non-diagnostic TCD monitoring endovascular procedure , subgroup 2 undergo intervention without TCD monitoring . Confirmation hypothesis sonothrombolysis able activate endogenous fibrinolytic system coronary angioplasty stenting consecutive reduction number volume brain infarct , lead increase safety patient . We presume 50 % patient indicate endovasular heart treatment treat use method future .</brief_summary>
	<brief_title>Sonolysis Risk Reduction Symptomatic Silent Brain Infarctions During Coronary Stenting</brief_title>
	<detailed_description>AIM OF THE PROJECT The aim project demonstrate effect continual TCD monitoring use 2 MHz diagnostic probe maximal diagnostic energy reduction risk brain microinfarctions due activation endogenous fibrinolytic system mechanical effect embolus coronary stenting . HYPOTHESIS Sonothrombolysis lead activation fibrinolytic system healthy volunteer acute stroke patient . In acute stroke patient , mechanical effect sonothrombolysis second effect lead acceleration occlude artery recanalization . We hypothesize combination mechanical effect activation fibrinolytic system sonothrombolysis ( TCD monitoring ) coronary stenting lead recanalization small arterial occlusion cause microembolization intervention . The result reduction volume number brain infarction . 120 patient indicate coronary stenting enrol study order demonstrate twenty-percent risk reduction number volume brain infarction detect use MRI examination 24 hour procedure 5 % level statistical significance . Patients randomize 2 subgroup . Subgroup 1 undergo non-diagnostic bilateral TCD monitoring coronary stenting . Subgroup 2 undergo coronary stenting without TCD monitoring . PATIENTS AND METHODS Patients : 120 patient indicate coronary angioplasty stenting enrol study 3-year period . All 120 patient randomized standard coronary angioplasty stenting TCD monitor . Clinical examination : Physical neurological examination include evaluate neurological impairment neurological deficit NIHSS scale , modify Rankin scale cognitive testing ( Mini Mental State Examination , Clock draw test ) perform 24 - 72 hour coronary angioplasty stenting . Randomization : Randomization use computer generate random allocation use . Sonothrombolysis : In patient randomized sonothrombolysis subgroup , bilateral MCA segment depth 55 mm monitor 40 - 240 minute use diagnostic 2 MHz probe maximal diagnostic energy . Non-diagnostic TCD monitoring perform without detection microembolic signal detection change blood flow . The second ( control ) subgroup undergo standard coronary angioplasty stenting without sonothrombolysis . MRI protocol consist 4 sequence : 1 . Localizer ; 2 . T2TSE ; 3 . FLAIR ; 4 . DWI . Sequences 1-3 applied level , slice thickness cut number . The slice thickness comprise cut thickness ( 5 mm ) + distant factor ( 30 % ) . Standard number slice 19 . Standard slice level consider modified level skull base due minimalization distant artifact EPI sequence . T2TSE : TR=4000/TE=99/ETL=9 , FOV 230 , FOV ph . 75 % , matrix 256x256 . FLAIR : 8050/112/ETL=21/2 conc. , FOV 230 , FOV ph . 76,6 % , matrix 256x151 . EPI-DWI : 4200/139/EPI f.=96/6 av. , FOV 230 , FOV ph . 100 % , phase enc . direction A-P , matrix 128x96 interpolation , phase partial Fourier 6/8 , Bw 1346 Hz/Px , echo space 0.83 m , TA . Sequence call `` trace '' three type MR picture every slice : ( ) T2*EPI b=0 ; ( b ) DWI b=500 ; ( c ) DWI b=1000 . The fourth type image automatically create ADC map ( in-line postprocessing ) . DWI show middle ( average ) diffusivity every point examine brain tissue b value 500 1000 . This sequence apply order ass hemorrhage ( T2*EPI ) monitor site reduce diffusion ( DWI , b=500 1000 ) . New infarction evaluate brain territory . Adverse effect : All adverse effect 1 month UM register , especially cause new admission hospital , worsen neurological symptom ( &gt; 4 point NIH stroke scale ) , brain edema , symptomatic asymptomatic intracranial bleeding detect control brain MRI . Study protocol approve Ethics Committees accordance principle guideline Declaration Helsinki , 1975 .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Brain Infarction</mesh_term>
	<criteria>age 3590 year sufficient temporal bone window TCD detectable blood flow MCA independent patient ( modify Rankin score 02 ) inform consent sign patient coronary angioplasty stenting perform elective procedure contraindication MRI examination ( pacemaker , implanted metal material , claustrophobia ) emergent coronary angioplasty stenting</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>sonolysis , brain infarction , coronary angioplasty</keyword>
</DOC>